Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Luigi Mangione
February 21, 2025 3:58 PM 3 min read

Luigi Mangione Lawyer Says 'Right To A Fair Trial' Compromised, Supporters Show Up To Court

by Chris Katje Benzinga Staff Writer
Follow

Luigi Mangione was back in court Friday for an update on the state charges against him in connection with the killing of UnitedHealthcare CEO Brian Thompson.

What Happened: Friday marked Mangione's first court date since December, when he pleaded not guilty to state charges. The suspected killer also faces federal charges, with the potential of the death penalty if convicted.

"My shock that the chief of detectives of the NYPD along with the NYC mayor had time to sit down with HBO and put hair and makeup and….talk about their theories of the case," Agnifilo said, as reported by Newsweek.

Mangione's lawyer said that his "right to a fair trial is continuously being impacted." His lawyer cited the Pennsylvania arrest at a McDonald's and said his client’s constitutional rights were violated there as well.

"I think there's a very serious search issue in this matter."

While discussing evidence in the case, Agnifilo said the defense team has not received the bulk of the discovery including police records, phone records or he so-called manifesto found on Mangione at the time of his arrest.

Items like DNA and forensic testing, policy body cam footage, witness statements and the autopsy report were turned over Friday, according to the report.

Judge Gregory Carro also said Mangione was to remain handcuffed during Friday's trial for his safety, something his lawyer took exception with and wanted on the record.

Read Also: UnitedHealthcare CEO Murder Suspect: Chronic Pain, Unabomber Fascination, Isolation Details Emerge

Why It's Important: The judge did not provide an update on the trial timeline in the case Friday. Mangione did not speak during Friday's hearing.

Mangione also faces federal charges that could include a death penalty sentence upon conviction. The accused killer has not yet entered a plea for the federal charges. Mangione's next court hearing on the federal charges is scheduled for March 19, according to the report.

A large group of supporters of the suspected killer were spotted outside the courtroom and inside the public gallery during Friday's trial. Some supporters had signs that read "patients before profits" and "Free Luigi."

A legal defense fund for Mangione has raised over $514,000 in donations through Friday, as reported by the New York Post. The funds are said to help pay Mangione's legal fees as he recently beefed up his legal team.

The online fundraiser reached its previous target and now has its sights set on raising $1 million.

Mangione thanked people for his support in his first statement from prison last week.

"I am overwhelmed by – and grateful for – everyone who has written me to share their stories and express their support," Mangione's statement said.

The company is now the subject of a Department of Justice investigation over its Medicare billing practices, which was announced Friday morning.

UNH Price Action: UnitedHealth stock is down 7.3% to $465.60 on Friday versus a 52-week trading range of $436.38 to $630.73. The stock is down 11% over the last year.

Read Next:

  • Luigi Mangione Documentaries In The Works From Award-Winning Creators — And Possibly Rapper 50 Cent

Luigi Mangione, who is charged in connection with the murder of UnitedHealthcare’s CEO. Photo via the Pennsylvania State Police.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
LegalTop StoriesMoversMediaTrading IdeasBrian ThompsonEric AdamsHBOHealth Insurancehealth insurance stocksnew yorkStories That Matter
UNH Logo
UNHUnitedHealth Group Inc
$292.65-0.18%
Overview
WBD Logo
WBDWarner Bros. Discovery Inc
$28.020.11%

Mangione's lawyer Karen Friedman Agnifilo called out several parties who appeared in a recent HBO true crime documentary on the Mangione case. Agnificlo said New York City Mayor Eric Adams and NYPD Chief of Detectives Joseph Kenny appeared on the documentary. HBO is a unit of Warner Bros. Discovery (NASDAQ:WBD).

UnitedHealthcare, which is owned by UnitedHealth Group (NYSE:UNH), is the largest individual player in Medicare Advantage with 7.8 million members, the company's latest earnings report revealed. The company also has 4.3 million members enrolled in Medicare supplement plans through UnitedHealthcare. It also has 3 million people enrolled in standalone Part D coverage.

UNH Logo
UNHUnitedHealth Group Inc
$292.65-0.18%
Overview
WBD Logo
WBDWarner Bros. Discovery Inc
$28.020.11%
Comments
Loading...